However, not everyone who takes fenofibrate will experience side effects. Patients with mild to moderate renal impairment CrCl 30-80 mL min or eGFR 30-59 mL min. In pivotal Phase III trials, LIVALO effectively reduced LDL-C and improved other parameters of lipid metabolism in special patient populations, including the elderly, patients with diabetes and patients at higher cardiovascular risk. The compositions of the invention can be used as adjunctive therapy to diet for the reduction of LDL-C, total-C, triglycerides, and Apo in adult patients with primary hypercholesterolemia or mixed dyslipidemia Fredrickson Types IIa and IIb. Dyslipidemia is fim comprar fenofibrate on-line well established as one of the strongest independent predictors of cardiovascular morbidity and mortality. Pharmacokinetics Plasma concentrations of fenofibric acid after single-dose administration of Fenofibrate Tablets, 120 mg are equivalent to those of Fenofibrate 130 mg capsules under high-fat conditions.